Delivery Order SPE2DX22D0010-SPE2D826FBM97
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Nucynta Tabs 50mg, a prescription pain management medication. This firm fixed-price delivery order carries a ceiling value of $4,442.48 and is scheduled for completion by December 10, 2025. The contract was competitively awarded without set-aside designation, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. This...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Nucynta 75 mg tablets (100-count units) valued at $30,223.35. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The U.S. Defense Department's Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. The contract ceiling value is $5,313.94, with an ultimate completion date of October 1, 2025. This is a non-set-aside award issued competitively to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which serves as a critical vendor for federal medical procurement...
- The U.S. Department of Defense Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta Tabs 100mg, a pain management pharmaceutical. This non-competitive, firm fixed-price delivery order, valued at $12,170.27, was issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $7,938.87, represents a non-competitive set-aside contract and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,315.96 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg, a pain management pharmaceutical. Issued on August 27, 2025, with an ultimate completion date of August 28, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $11,234.27 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The U.S. Defense Department's Medical Supply Chain awarded a $11,313.88 delivery order to AmerisourceBergen Drug Corp on October 1, 2025, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitive, firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,375.14 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $13,932.13 for Nucynta Tabs 75mg, a pain management pharmaceutical product. This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBM97Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed price delivery order, valued at $10,788.15 with completion targeted for December 5, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor with extensive experience fulfilling Defense Logistics Agency requirements. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The prime IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent capability in delivering diverse pharmaceutical commodities across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 12/3/25 |